细胞毒性T细胞
淋巴细胞性脉络膜脑膜炎
CD8型
生物
免疫系统
免疫检查点
癌症免疫疗法
癌症研究
克隆(Java方法)
免疫
免疫疗法
免疫学
遗传学
生物化学
体外
DNA
作者
Martin W. LaFleur,Thao H. Nguyen,Matthew Coxe,Brian C. Miller,Kathleen B. Yates,Jacob E. Gillis,Debattama R. Sen,Emily F. Gaudiano,Rose Al Abosy,Gordon J. Freeman,W. Nicholas Haining,Arlene H. Sharpe
出处
期刊:Nature Immunology
[Nature Portfolio]
日期:2019-09-16
卷期号:20 (10): 1335-1347
被引量:191
标识
DOI:10.1038/s41590-019-0480-4
摘要
CD8+ T cell exhaustion is a state of dysfunction acquired in chronic viral infection and cancer, characterized by the formation of Slamf6+ progenitor exhausted and Tim-3+ terminally exhausted subpopulations through unknown mechanisms. Here we establish the phosphatase PTPN2 as a new regulator of the differentiation of the terminally exhausted subpopulation that functions by attenuating type 1 interferon signaling. Deletion of Ptpn2 in CD8+ T cells increased the generation, proliferative capacity and cytotoxicity of Tim-3+ cells without altering Slamf6+ numbers during lymphocytic choriomeningitis virus clone 13 infection. Likewise, Ptpn2 deletion in CD8+ T cells enhanced Tim-3+ anti-tumor responses and improved tumor control. Deletion of Ptpn2 throughout the immune system resulted in MC38 tumor clearance and improved programmed cell death-1 checkpoint blockade responses to B16 tumors. Our results indicate that increasing the number of cytotoxic Tim-3+CD8+ T cells can promote effective anti-tumor immunity and implicate PTPN2 in immune cells as an attractive cancer immunotherapy target.
科研通智能强力驱动
Strongly Powered by AbleSci AI